Diagnosis: Carcinoembryonic Antigen
The carcinoembryonic antigen (CEA) test is a blood test that measures the level of CEA protein in the blood. The CEA protein is present in the developing embryo, but disappears from the blood by birth and normally remains at undetectable levels throughout adulthood. When CEA does appear in the blood of an adult, it may indicate presence of a cancer, including pancreatic cancer. However, the test is not used to diagnose pancreatic cancer because the CEA protein is not produced by all pancreatic tumors. Other tumors, such as colon cancer, may also cause a rise in CEA. In addition, other factors, such as smoking, can increase CEA concentration in the blood even when no cancer is present. Similar to CA 19-9, CEA cannot be used as a diagnostic or screening test for pancreatic cancer. Measuring blood CEA levels is most effective to monitor if an existing pancreatic tumor is responding to treatment. If a pancreatic tumor produces the CEA protein and surgery is performed to remove the tumor, CEA levels in the blood should return to normal.
The information and services provided by the Pancreatic Cancer Action Network, Inc. are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. If you are ill, or suspect that you are ill, see a doctor immediately! The Pancreatic Cancer Action Network does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site. In addition, please note that any personal information you provide to the Pancreatic Cancer Action Network's associates during telephone and/or email consultations may be stored in a secure database to assist the Pancreatic Cancer Action Network, Inc. in providing you with the best service possible. Portions of the constituent data stored in this database may be used to inform future programs and services of the Pancreatic Cancer Action Network, Inc., and may be provided in aggregate form to third parties to guide future pancreatic cancer research and treatment efforts. The Pancreatic Cancer Action Network, Inc. will not provide personal identifying information (such as your name or contact information) to third parties without your advanced written consent. 080923